Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial

NCT05135546 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped No patients

Conditions

COVID-19

Interventions

DRUG: Recombinant nonimmunogenic staphylokinase
DRUG: Placebo

Sponsor

Supergene, LLC

Collaborators

[object Object]